The latest report by IMARC Group, titled "Nerve Repair and Regeneration Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028", offers a comprehensive analysis of the industry, which comprises insights on the global nerve repair and regeneration market trends. The global nerve repair and regeneration market size reached US$ 7.7 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 14.8 Billion by 2028, exhibiting a growth rate (CAGR) of 11.3% during 2023-2028.

Nerve repair and regeneration (NRaR) is performed to support the replacement of injured nervous tissue caused by trauma or neurodegenerative diseases. It promotes the regrowth of new neurons, myelin, axon, synapses, and glial cells to restore normal nerve functionalities. NRaR employs biomaterials, along with neurostimulation and neuromodulation devices, for conducting nerve grafting, direct Neurotherapy, stem cell therapy, transcranial magnetic, and sacral nerve stimulation. As a result, they are extensively applied in cell relocation studies, material sciences, and nanotechnology and bioengineering fields.

Request for a sample copy of this report: https://www.imarcgroup.com/nerve-repair-regeneration-market/requestsample

Nerve Repair and Regeneration Market Trends and Drivers:

The increasing prevalence of neurological disorders and rising incidents of nervous injuries, especially in the geriatric population, represent the key factors contributing to the global NRaR market growth. In line with this, extensive research and development (R&D) activities in the field of neurology to introduce advanced NRaR products are further catalyzing market growth. Moreover, rising healthcare expenditure and the widespread adoption of effective management and treatment strategies, such as endogenous and exogenous stem cell transplantation, are positively influencing the market growth.

Competitive Landscape:

The competitive landscape of the market has been studied in the report with the detailed profiles of the key players operating in the market.

Some of these key players include:

  • Abbott Laboratories
  • Alafair Biosciences Inc.
  • AxoGen Inc.
  • Baxter International Inc.
  • Boston Scientific Corporation
  • Collagen Matrix Inc
  • Integra Lifesciences Corporation
  • Medtronic plc
  • Polyganics BV
  • Soterix Medical Inc.
  • Stryker Corporation
  • Synapse Biomedical Inc.

Ask Analyst for Sample Report: https://www.imarcgroup.com/request?type=report&id=4159&flag=C

The report has segmented the market on the basis of Product Type, End-User and Region.

Breakup by Surgery:

  • Direct Nerve Repair/Neurorrhaphy
  • Nerve Grafting
  • Stem Cell Therapy
  • Neurostimulation and Neuromodulation Surgeries

Breakup by Product:

  • Biomaterial
  • Neurostimulation and Neuromodulation Devices
    • Spinal Cord Stimulation Devices
    • Deep Brain Stimulation Devices
    • Sacral Nerve Stimulation Devices
    • Vagus Nerve Stimulation Devices
    • Gastric Electric Stimulation Devices

Breakup by End User:

  • Hospitals and Clinics
  • Ambulatory Surgical Centers

Market Breakup by Region:

  • North America (United States, Canada)
  • Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, Others)
  • Europe (Germany, France, United Kingdom, Italy, Spain, Russia, Others)
  • Latin America (Brazil, Mexico, Others)
  • Middle East and Africa

If you need specific information that is not currently within the scope of the report, we will provide it to you as a part of the customization.

About Us

IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.

Contact US

IMARC Group

Email: [email protected]

USA: +1-631-791-1145 | Asia: +91-120-433-0800

Address: 134 N 4th St. Brooklyn, NY 11249, USA

Follow us on Twitter: @imarcglobal